Prediction of capsular perforation and seminal vesicle invasion in prostate cancer

Journal of Urology

Volumn 155, Issue 4, 1996, Pages 1361-1367

  Bostwick, David G ^a   Qian, Junqi ^a   Bergstralh, Erik ^a   Dundore, Paul ^a   Dugan, James ^a   Myers, Robert P ^a   Oesterling, Joseph E ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

adenocarcinoma; prostate; prostate specific antigen; prostatectomy; seminal vesicles

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; SEMINAL VESICLE;

EID: 0029916141     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66267-0     Document Type: Article

References (36)

1. Byar, D. P. and Mostofi, F. K.: Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer, 30: 5, 1972.
2. Cheng, W. S., Frydenberg, M., Bergstralh, E. J., Larson-Keller, J. J. and Zincke, H.: Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology, 42: 283, 1993.
3. Ravery, V., Boccon-Gibod, L. A., Dauge-Geffroy, M. C., Delmas, V., Meulemans, A., Toublanc, M. and Boccon-Gibod, L.: Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology, 44: 371, 1994.
4. McNeal, J. E., Bostwick, D. G., Kindrachuk, R. A., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Patterns of progression in prostate cancer. Lancet, 1: 60, 1986.
5. McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Capsular penetration in prostate cancer. Significance for natural history and treatment. Amer. J. Surg. Path., 14: 240, 1990.
6. Hering, F., Rist, M., Roth, J., Mihatsch, M. and Rutishauser, G.: Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy? Brit. J. Urol., 66: 177, 1990.
7. Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, F., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 141: 1076, 1989.
8. Kleer, E., Larson-Keller, J. J., Zincke, H. and Oesterling, J. E.: Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. Urology, 41: 207, 1993.
9. Mukamel, E., deKernion, J. B., Dorey, F. and Hannah, J.: Significance of histological prognostic indicators in patients with carcinoma of the prostate. Brit. J. Urol., 65: 46, 1990.
10. Paulson, D. F., Stone, A. R., Walther, P. J., Tucker, J. A. and Cox, E. B.: Radical prostatectomy: anatomical predictors of success or failure. J. Urol., 136: 1041, 1986.
11. Middleton, R. G., Smith, J. A., Jr., Melzer, R. B. and Hamilton, P. E.: Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma. J. Urol., 136: 422, 1986.
12. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: The use of prostate specific antigen, clinical stage, and Gleason score to predict pathologic stage in men with localized prostate cancer. J. Urol., 150:110, 1993.
13. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
14. Ohori, M., Scardino, P. T., Lapin, S. L., Seale-Hawkins, C., Link, J. and Wheeler, T. M.: The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Amer. J. Surg. Path., 17: 1252, 1993.
15. Villers, A. A., McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J. Urol., 143: 1183, 1990.
16. Mukamel, E., deKernion, J. B., Hannah, T., Smith, R. B., Skinner, D. G. and Goodwin, W. E.: The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer, 59: 1535, 1987.
17. Epstein, J. I., Carmichael, M. and Walsh, P. C.: Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J. Urol., 149: 1040, 1993.
18. Zincke, H., Farrow, G. M., Utz, D. C., Patterson, D. E., Myers, R. P. and Furlow, W. L.: Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of prostate with regional lymph node involvement. Urology, 19: 238, 1982.
19. Zincke, H., Utz, D. C., Benson, R. C., Jr. and Patterson, D. E.: Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C adenocarcinoma of the prostate. Urology, 24: 532, 1984.
20. Scaletscky, R., Koch, M. O., Eckstein, C. W., Bicknell, S. L., Gray, G. F., Jr. and Smith, J. A., Jr.: Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen. J. Urol., 152: 129, 1994.
21. Oesterling, J. E., Brendler, C. B., Epstein, J. I., Kimball, A. W., Jr. and Walsh, P. C.: Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathologic stage in 275 patients with clinically localized adenocarcinoma of the prostate. J. Urol., 138: 92, 1987.
22. Schroder, F. H., Hermanek, P., Denis, L., Fair, W. R., Gospodarowicz, M. K. and Pavone-Macaluso, M.: The TNM classification of prostate cancer. Prostate, suppl., 4:129, 1992.
23. Friedman, G. D., Hiatt, R. A., Quesenberry, C. P., Jr. and Selby, J. V.: Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet, 337: 1526, 1991.
24. Oesterling, J. E., Martin, S. K., Bergstralh, E. J. and Lowe, F. C.: The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. J.A.M.A., 269: 57, 1993.
25. Fielding, L. P., Fenoglio-Preiser, C. M. and Freedman, L. S.: The future of prognostic factors in outcome prediction for patients with cancer. Cancer, 70: 2367, 1992.
26. Myrtle, J. F., Klimley, P. G., Ivor, L. P. and Bruni, J. F.: Clinical utility of prostate-specific antigen (PSA) in the management of prostate cancer. In: Advances in Cancer Diagnosis. La Jolla, California: Hybritech, Inc., 1986.
27. Cupp, M. R., Bostwick, D. G., Myers, R. P. and Oesterling, J. E.: The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J. Urol., 153: 1543, 1995.
28. Bostwick, D. G., Myers, R. P. and Oesterling, J. E.: Staging of prostate cancer. Sem. Surg. Oncol., 10: 60, 1994.
29. Ackerman, D. A., Barry, J. M., Wicklund, R. A., Olson, N. and Lowe, B. A.: Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J. Urol., 150: 1845, 1993.
30. Epstein, J. I., Walsh, P. C., Carmichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1e) prostate cancer. J.A.M.A., 271: 368, 1994.
31. Bastacky, S. I., Walsh, P. C. and Epstein, J. I.: Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Amer. J. Surg. Path., 17: 336, 1993.
32. Villers, A., McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J. Urol., 142: 763, 1989.
33. Takahashi, S., Qian, J., Brown, J. A., Alcaraz, A., Bostwick, D. G., Lieber, M. M. and Jenkins, R. B.: Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res., 54: 3574, 1994.
34. Terris, M. K., McNeal, J. E., Freiha, F. S. and Stamey, T. A.: Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J. Urol., 149: 1035, 1993.
35. Rifkin, M. D., Zerhouni, E. A., Gatsonis, C. A., Quint, L. E., Paushter, D. M., Epstein, J. I., Hamper, U., Walsh, P. C. and McNeil, B. J.: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. New Engl. J. Med., 323: 621, 1990.
36. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C. and Buttyan, R.: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765, 1994.